https://orcid.org/0000-0002-1608-876X
Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Andrew B. Song & Hanny Al-Samkari. (2023) Emerging data on thrombopoietin receptor agonists for management of chemotherapy-induced thrombocytopenia. Expert Review of Hematology 16:5, pages 365-375.
Read now
Read now
Ondine Walter, Agnès Ribes, Johanne Germain, Jean-Baptiste Rieu, Thibaut Comont, Albertine Plat, Brigitte Rivière, Laureline Deluche, Lucrecia Delarue, Isabelle LeGoff, Monique Greze, Béatrice Dubourdieu, Odile Rauzy, Veronique Mansat-De Mas & Guillaume Moulis. (2022) Association between megakaryocyte abnormalities on bone marrow smear and response to thrombopoietin receptor agonists in adult patients with primary immune thrombocytopenia. Platelets 33:8, pages 1153-1158.
Read now
Read now
Huinan Jiang, Yanwei Li, Qiuju Sheng & Xiaoguang Dou. (2022) Relationship between Hepatitis B virus infection and platelet production and dysfunction. Platelets 33:2, pages 212-218.
Read now
Read now
James B Bussel, Gerald Soff, Adriana Balduzzi, Nichola Cooper, Tatiana Lawrence & John W Semple. (2021) A Review of Romiplostim Mechanism of Action and Clinical Applicability. Drug Design, Development and Therapy 15, pages 2243-2268.
Read now
Read now
Maria L. Lozano, Bertrand Godeau, John Grainger, Axel Matzdorff, Francesco Rodeghiero, Jane Hippenmeyer & David J. Kuter. (2020) Romiplostim in adults with newly diagnosed or persistent immune thrombocytopenia. Expert Review of Hematology 13:12, pages 1319-1332.
Read now
Read now
Articles from other publishers (23)
Thomas Moulinet, Anthony Moussu, Ludovic Pierson & Simona Pagliuca. (2023) The many facets of immune-mediated thrombocytopenia: Principles of immunobiology and immunotherapy. Blood Reviews, pages 101141.
Crossref
Crossref
Tomás José González‐López & Alexandra Schifferli. (2023)
Early immunomodulation in immune thrombocytopenia—A report of the
ICIS
meeting in Lenzerheide, Switzerland 2022
. British Journal of Haematology 203:1, pages 101-111.
Crossref
Crossref
Alexandra Schifferli, Axel Rüfer, Alicia Rovo, Falk Nimmerjahn, Nathan Cantoni, Andreas Holbro, Geneviève Favre, Jan Dirks, Anna Wieland, Heike Faeth, Renata Pereira & Thomas Kühne. (2023)
Immunomodulation with romiplostim as a second‐line strategy in primary immune thrombocytopenia: The
iROM
study
. British Journal of Haematology 203:1, pages 119-130.
Crossref
Crossref
Tomás José González-López, Drew Provan, Abelardo Bárez, Angel Bernardo-Gutiérrez, Silvia Bernat, Daniel Martínez-Carballeira, Isidro Jarque-Ramos, Inmaculada Soto, Reyes Jiménez-Bárcenas & Fernando Fernández-Fuertes. (2023) Primary and secondary immune thrombocytopenia (ITP): Time for a rethink. Blood Reviews 61, pages 101112.
Crossref
Crossref
Masoud Kargar, Mehdi Torabizadeh, Daryush Purrahman, Zeinab Deris Zayeri & Najmaldin Saki. (2023) Regulatory factors involved in Th17/Treg cell balance of immune thrombocytopenia. Current Research in Translational Medicine 71:2, pages 103389.
Crossref
Crossref
Rick Kapur. (2022) Regulatory T cells are replenished in the splenic microenvironment of patients with immune thrombocytopenia by treatment with thrombopoietin receptor agonists. British Journal of Haematology 198:5, pages 803-804.
Crossref
Crossref
Marco Pizzi, Fabrizio Vianello, Gianni Binotto, Nicola Vianelli, Giuseppe Carli, Giuseppe Auteri, Ilaria Nichele, Marta Sbaraglia, Simone Zoletto, Federico Scarmozzino, Rita Bresciani, Fabio d'Amore, Alberto Friziero, Vincenza Guzzardo, Irene Bertozzi, Barbara Famengo, Emanuele S. G. d'Amore, Elena Sabattini & Angelo Paolo Dei Tos. (2022) Thrombopoietin receptor agonists increase splenic regulatory T‐cell numbers in immune thrombocytopenia. British Journal of Haematology 198:5, pages 916-922.
Crossref
Crossref
Rick Kapur. (2022) Impaired glucocorticoid receptor expression and mitochondrial metabolism in MDSCs contribute to glucocorticoid resistance in immune thrombocytopenia. Cellular & Molecular Immunology 19:7, pages 858-860.
Crossref
Crossref
Min Soon Cho, Hani Lee, Ricardo Gonzalez-Delgado, Dan Li, Tomoyuki Sasano, Wendolyn Carlos-Alcalde, Qing Ma, Jinsong Liu, Anil K. Sood & Vahid Afshar-Kharghan. (2022) Platelets Increase the Expression of PD-L1 in Ovarian Cancer. Cancers 14:10, pages 2498.
Crossref
Crossref
Heng Mei, Xiaofan Liu, Yan Li, Hu Zhou, Ying Feng, Guangxun Gao, Peng Cheng, Ruibin Huang, Linhua Yang, Jianda Hu, Ming Hou, Yazhou Yao, Li Liu, Yi Wang, Depei Wu, Liansheng Zhang, Changcheng Zheng, Xuliang Shen, Qi Hu, Jing Liu, Jie Jin, Jianmin Luo, Yun Zeng, Sujun Gao, Xiaohui Zhang, Xin Zhou, Qingzhi Shi, Ruixiang Xia, Xiaobao Xie, Zhongxing Jiang, Li Gao, Yuansong Bai, Yan Li, Junye Xiong, Runzi Li, Jianjun Zou, Ting Niu, Renchi Yang & Yu Hu. (2022) Dose tapering to withdrawal stage and long‐term efficacy and safety of hetrombopag for the treatment of immune thrombocytopenia: Results from an open‐label extension study. Journal of Thrombosis and Haemostasis 20:3, pages 716-728.
Crossref
Crossref
Kensaku Nakai, Takuya Misugi, Kohei Kitada, Yasushi Kurihara, Mie Tahara, Akihiro Hamuro, Akemi Nakano, Masayasu Koyama, Yukimi Kira & Daisuke Tachibana. (2022) Effect of Thrombopoietin Receptor Agonist on Pregnant Mice. Pharmaceutics 14:3, pages 514.
Crossref
Crossref
Yuwen Chen, Jianda Hu & Yingyu Chen. (2021) Platelet desialylation and TFH cells–the novel pathway of immune thrombocytopenia. Experimental Hematology & Oncology 10:1.
Crossref
Crossref
Heng Mei, Xiaofan Liu, Yan Li, Hu Zhou, Ying Feng, Guangxun Gao, Peng Cheng, Ruibin Huang, Linhua Yang, Jianda Hu, Ming Hou, Yazhou Yao, Li Liu, Yi Wang, Depei Wu, Liansheng Zhang, Changcheng Zheng, Xuliang Shen, Qi Hu, Jing Liu, Jie Jin, Jianmin Luo, Yun Zeng, Sujun Gao, Xiaohui Zhang, Xin Zhou, Qingzhi Shi, Ruixiang Xia, Xiaobao Xie, Zhongxing Jiang, Li Gao, Yuansong Bai, Yan Li, Junye Xiong, Runzi Li, Jianjun Zou, Ting Niu, Renchi Yang & Yu Hu. (2021) A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopenia. Journal of Hematology & Oncology 14:1.
Crossref
Crossref
Soo-hyun Kim, In-kyo Seo, Hye-in Jeong, Jun-hyung Kim, Sang-woo Jeon, Su-bin Ahn & Sei-young Kang. (2021) A Suspected Case of Idiopathic Thrombocytopenic Purpura - A Case Report. The Journal of Internal Korean Medicine 42:5, pages 1074-1081.
Crossref
Crossref
Anastasia A. Ignatova, Elena V. Suntsova, Alexey V. Pshonkin, Alexey A. Martyanov, Evgeniya A. Ponomarenko, Dmitry M. Polokhov, Daria V. Fedorova, Kirill A. Voronin, Natalia N. Kotskaya, Natalia M. Trubina, Marina V. Krasilnikova, Selima Sh. Uzueva, Irina V. Serkova, Galina S. Ovsyannikova, Ksenia I. Romanova, Lili A. Hachatryan, Irina I. Kalinina, Viktor E. Matveev, Maya N. Korsantiya, Natalia S. Smetanina, Dmitry A. Evseev, Maria N. Sadovskaya, Kristina S. Antonova, Anna L. Khoreva, Pavel A. Zharkov, Anna Shcherbina, Anastasia N. Sveshnikova, Aleksey A. Maschan, Galina A. Novichkova & Mikhail A. Panteleev. (2021) Platelet function and bleeding at different phases of childhood immune thrombocytopenia. Scientific Reports 11:1.
Crossref
Crossref
Marie NollaNathalie AladjidiThierry LeblancHelder FernandesStéphane DucassouMony FahdVincent Barlogis, Marc MichelPascale BlouinEric Jeziorski, Joy BenadibaCorinne PondarreGuy Leverger & Marlene Pasquet. (2021) Thrombopoietin receptor agonists as an emergency treatment for severe newly diagnosed immune thrombocytopenia in children. Blood 137:1, pages 138-141.
Crossref
Crossref
Emily L. Williams, Madeleine L. Stimpson, Philippa J. P. Lait, Lauren P. Schewitz‐Bowers, Lauren V. Jones, Ashwin D. Dhanda, Richard W. J. Lee & Charlotte A. Bradbury. (2020)
Glucocorticoid treatment in patients with newly diagnosed immune thrombocytopenia switches CD14
++
CD16
+
intermediate monocytes from a pro‐inflammatory to an anti‐inflammatory phenotype
. British Journal of Haematology 192:2, pages 375-384.
Crossref
Crossref
John W. Semple, Johan Rebetz, Amal Maouia & Rick Kapur. (2020) An update on the pathophysiology of immune thrombocytopenia. Current Opinion in Hematology 27:6, pages 423-429.
Crossref
Crossref
Fei Gao, Xiaoyu Zhou, Jimin Shi, Yi Luo, Yamin Tan, Huarui Fu, Xiaoyu Lai, Jian Yu, He Huang & Yanmin Zhao. (2020) Eltrombopag treatment promotes platelet recovery and reduces platelet transfusion for patients with post-transplantation thrombocytopenia. Annals of Hematology 99:11, pages 2679-2687.
Crossref
Crossref
Maria Gavriatopoulou, Ajai Chari, Christine Chen, Nizar Bahlis, Dan T. Vogl, Andrzej Jakubowiak, David Dingli, Robert F. Cornell, Craig C. Hofmeister, David Siegel, Jesus G. Berdeja, Donna Reece, Darrell White, Suzanne Lentzsch, Cristina Gasparetto, Carol Ann Huff, Sundar Jagannath, Rachid Baz, Ajay K. Nooka, Joshua Richter, Rafat Abonour, Terri L. Parker, Andrew J. Yee, Philippe Moreau, Sagar Lonial, Sascha Tuchman, Katja C. Weisel, Mohamad Mohty, Sylvain Choquet, T. J. Unger, Kai Li, Yi Chai, Lingling Li, Jatin Shah, Sharon Shacham, Michael G. Kauffman & Meletios Athanasios Dimopoulos. (2020) Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials. Leukemia 34:9, pages 2430-2440.
Crossref
Crossref
Elena Monzón Manzano, María Teresa Álvarez Román, Raúl Justo Sanz, Ihosvany Fernández Bello, Diana Hernández, Mónica Martín Salces, Larissa Valor, Isabel Rivas Pollmar, Nora V. Butta & Víctor Jiménez Yuste. (2020) Platelet and immune characteristics of immune thrombocytopaenia patients non‐responsive to therapy reveal severe immune dysregulation. British Journal of Haematology 189:5, pages 943-953.
Crossref
Crossref
Marcel G.E. Rommel, Keven Hoerster, Christian Milde, Franziska Schenk, Luise Roser, Saskia Kohlscheen, Niels Heinz & Ute Modlich. (2020) Signaling properties of murine MPL and MPL mutants after stimulation with thrombopoietin and romiplostim. Experimental Hematology 85, pages 33-46.e6.
Crossref
Crossref
Michał Witkowski, Magdalena Witkowska & Tadeusz Robak. (2019) Autoimmune thrombocytopenia: Current treatment options in adults with a focus on novel drugs. European Journal of Haematology 103:6, pages 531-541.
Crossref
Crossref